BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26674651)

  • 1. Cellular Antiviral Factors that Target Particle Infectivity of HIV-1.
    Goffinet C
    Curr HIV Res; 2016; 14(3):211-6. PubMed ID: 26674651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.
    Lodermeyer V; Ssebyatika G; Passos V; Ponnurangam A; Malassa A; Ewald E; Stürzel CM; Kirchhoff F; Rotger M; Falk CS; Telenti A; Krey T; Goffinet C
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
    Trautz B; Pierini V; Wombacher R; Stolp B; Chase AJ; Pizzato M; Fackler OT
    J Virol; 2016 Dec; 90(23):10915-10927. PubMed ID: 27681140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Heterogeneity of Mammalian IFITM Proteins against HIV-1.
    Marziali F; Delpeuch M; Kumar A; Appourchaux R; Dufloo J; Tartour K; Etienne L; Cimarelli A
    J Virol; 2021 Aug; 95(18):e0043921. PubMed ID: 34160255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1.
    Lodermeyer V; Suhr K; Schrott N; Kolbe C; Stürzel CM; Krnavek D; Münch J; Dietz C; Waldmann T; Kirchhoff F; Goffinet C
    Retrovirology; 2013 Oct; 10():111. PubMed ID: 24156545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M2BP inhibits HIV-1 virion production in a vimentin filaments-dependent manner.
    Wang Q; Zhang X; Han Y; Wang X; Gao G
    Sci Rep; 2016 Sep; 6():32736. PubMed ID: 27604950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1.
    Colomer-Lluch M; Ruiz A; Moris A; Prado JG
    Front Immunol; 2018; 9():2876. PubMed ID: 30574147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
    Compton AA; Bruel T; Porrot F; Mallet A; Sachse M; Euvrard M; Liang C; Casartelli N; Schwartz O
    Cell Host Microbe; 2014 Dec; 16(6):736-47. PubMed ID: 25464829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apobec3G-Based Strategies to Defeat HIV Infection.
    Ran X; Ao Z; Yao X
    Curr HIV Res; 2016; 14(3):217-24. PubMed ID: 26957196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
    Tartour K; Appourchaux R; Gaillard J; Nguyen XN; Durand S; Turpin J; Beaumont E; Roch E; Berger G; Mahieux R; Brand D; Roingeard P; Cimarelli A
    Retrovirology; 2014 Nov; 11():103. PubMed ID: 25422070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.
    Tartour K; Nguyen XN; Appourchaux R; Assil S; Barateau V; Bloyet LM; Burlaud Gaillard J; Confort MP; Escudero-Perez B; Gruffat H; Hong SS; Moroso M; Reynard O; Reynard S; Decembre E; Ftaich N; Rossi A; Wu N; Arnaud F; Baize S; Dreux M; Gerlier D; Paranhos-Baccala G; Volchkov V; Roingeard P; Cimarelli A
    PLoS Pathog; 2017 Sep; 13(9):e1006610. PubMed ID: 28957419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HIV Factors: Targeting Each Step of HIV's Replication Cycle.
    Colomer-Lluch M; Gollahon LS; Serra-Moreno R
    Curr HIV Res; 2016; 14(3):175-82. PubMed ID: 26957194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dodging the Host Interferon-Stimulated Gene Mediated Innate Immunity by HIV-1: A Brief Update on Intrinsic Mechanisms and Counter-Mechanisms.
    Chintala K; Mohareer K; Banerjee S
    Front Immunol; 2021; 12():716927. PubMed ID: 34394123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Same same but different - Antiviral factors interfering with the infectivity of HIV particles.
    Kriesel F; Schelle L; Baldauf HM
    Microbes Infect; 2020 Oct; 22(9):416-422. PubMed ID: 32450247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced Packaging of Cellular MicroRNAs into HIV-1 Virions Can Inhibit Infectivity.
    Bogerd HP; Kennedy EM; Whisnant AW; Cullen BR
    mBio; 2017 Jan; 8(1):. PubMed ID: 28096489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment.
    Xie M; Xuan B; Shan J; Pan D; Sun Y; Shan Z; Zhang J; Yu D; Li B; Qian Z
    J Virol; 2015 Mar; 89(6):3049-61. PubMed ID: 25552713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of interferon inducible trans-membrane proteins and retinoic acid inducible gene I for influenza virus replication: A review.
    Suo S; Ren X
    Crit Rev Microbiol; 2016; 42(1):75-82. PubMed ID: 25811941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Early Bird Catches the Worm--Can Evolution Teach us Lessons in Fighting HIV?
    Schaller T; Herold N
    Curr HIV Res; 2016; 14(3):183-210. PubMed ID: 26957195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
    Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of HIV-1 Env on SERINC5 Antagonism.
    Beitari S; Ding S; Pan Q; Finzi A; Liang C
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.